TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) › Capital ExpendituresTEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — Capital ExpendituresAnnual figures by period end, from SEC filings.2021-12-31: $562.00M2022-12-31: $548.00M2023-12-31: $526.00M2024-12-31: $498.00M2025-12-31: $501.00M$501.00M2021-12-31Capital Expenditures (USD)2025-12-31Period endedCapital ExpendituresChange YoYSource filing2025-12-31$501.00M+0.6%2026-02-03From 2025-01-012024-12-31$498.00M-5.3%2026-02-03From 2024-01-012023-12-31$526.00M-4.0%2026-02-03From 2023-01-012022-12-31$548.00M-2.5%2025-02-05From 2022-01-012021-12-31$562.00M—2024-02-12From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)